How Long Is Too Long to Go Without a Period With PCOS (Now PMOS)?

You counted back to the last one and the number surprised you. Sixty days. Ninety. Maybe you stopped counting somewhere around month five, because counting had started to feel like worrying on purpose.

Then you searched, and the internet gave you two answers at once. One says three months is the line. The other says women with PCOS — now PMOS, after the 2026 Lancet consensus renamed it Polyendocrine Metabolic Ovarian Syndrome — routinely go six months or a year and it is simply how the condition behaves. Both of those are repeated everywhere. Neither one tells you what to do on a Tuesday in month four.

There is a real number. It comes from a guideline rather than a blog, it is more specific than "three months," and it means something narrower than most pages imply.

The number is 90 days, and it comes with a definition attached

The 2023 International Evidence-Based Guideline sets out exactly what counts as an irregular cycle, and it does it by how long you have been menstruating rather than by age:

• First year after your first period: irregular cycles are normal. This is the pubertal transition, not a finding.
• One to three years after menarche: shorter than 21 days, or longer than 45 days.
• Three years after menarche through to perimenopause: shorter than 21 days, longer than 35 days, or fewer than eight cycles in a year.
• At any point from one year after menarche: more than 90 days for any single cycle.

That last line is the one you were looking for. Ninety days is the threshold at which a single gap stops being within the normal range and becomes something to have assessed.

Notice the second threshold too, because it catches people the first one misses. Fewer than eight bleeds in twelve months meets the definition even if no individual gap ever reaches 90 days. Cycles of 50 days, every time, never trip the 90-day wire — and still qualify.

What the number is not: it is not a danger line, and crossing it is not an emergency. It is a definition. It means the cycle has moved outside the normal range and is worth a proper look, which is a considerably calmer instruction than most of the internet gives you.

What those 90 days are actually measuring

The mechanism is straightforward. In a cycle that ovulates, oestrogen thickens the lining of the uterus, then progesterone — which only appears after ovulation — matures it and triggers the bleed that clears it. When ovulation does not happen, progesterone never arrives. The lining keeps seeing oestrogen with nothing opposing it.

That is why the gap matters at all. It is not the missing bleed itself; it is the months of unopposed oestrogen the missing bleed stands for.

Now the honest proportion, because this is where a lot of pages overshoot. The 2023 guideline states plainly that premenopausal women with PMOS have a markedly higher risk of endometrial hyperplasia and endometrial cancer — and, in the same passage, that the overall chance of developing endometrial cancer is low, and routine screening is not recommended. Both halves are the guideline's position. A large prospective cohort puts a number on the general version of this: following 78,943 women in the Nurses' Health Study II, those reporting irregular cycles in mid-adulthood had a 39% higher risk of endometrial cancer than women with very regular cycles, after adjusting for body mass index. A relative increase of that size, applied to a cancer that is genuinely uncommon before menopause, is a reason to act — not a reason to be frightened. We have written up what the endometrial, breast and ovarian evidence does and doesn't say separately.

One thing we want to be straight about, because we have not seen anyone else say it. The "aim for a bleed at least every three months" rule that appears on nearly every page about this — including, in a hedged form, on ours — is clinical convention. It is sensible convention. But the 2023 guideline does not name an interval. What it actually recommends is that women with PMOS be told about the risk and about preventative strategies: weight management, cycle regulation, and regular progestogen therapy. The strategies are specified. The number of months is not. If a page presents "every three months" as a guideline instruction, it has tidied up the evidence a little.

If you are trying to conceive, this is the wrong number to watch

Here is the branch almost nobody draws, and it changes what you should be asking for.

There are two entirely different reasons to care about a long gap. One is protecting the lining of the uterus. The other is ovulating. They are related, and they are not the same, and the standard fix for the first does nothing for the second.

A progestogen-induced withdrawal bleed clears the lining. That is real and it is useful. But it is not ovulation, and it does not mean an egg was released. If you are not trying to conceive, a bleed is a reasonable endpoint to aim at. If you are, a bleed is close to meaningless on its own — the question becomes whether you are ovulating, and that is measured differently: mid-luteal progesterone, tracking, or a conversation about ovulation induction. Watching the calendar for blood, in that situation, can give you months of false reassurance.

This is worth saying out loud at an appointment, because "we'll give you something to bring your period back" answers one of those questions and not the other.

When a long gap is probably not your PMOS

A PMOS diagnosis does not stop other things happening, and long gaps have several causes that get filed under "just my PMOS" for years. This is a checklist of reasons to get assessed rather than wait — not a way to work out the answer yourself, which needs bloods and a clinician.

• A pregnancy test first, every time. Unglamorous, and it is genuinely the first step.
• Periods that stopped after hormonal contraception. Different pattern, different workup — we have covered what post-pill amenorrhoea actually is.
• Cycles that were regular and then stopped fairly abruptly. PMOS irregularity tends to be long-standing. A clear before-and-after points elsewhere.
• Milky nipple discharge, or new persistent headaches or visual changes. Prolactin, and worth raising promptly.
• Marked fatigue, cold intolerance, or a change in weight without a change in habits. Thyroid disease is common, treatable, and imitates a lot of this — see fatigue that isn't PMOS.
• Hard training, low intake, or significant weight loss. Low energy availability suppresses cycles through a completely different mechanism, and it responds to the opposite advice.
• Hot flushes or night sweats alongside the gaps. The perimenopause overlap is real, and so is premature ovarian insufficiency.
• Any bleeding that is heavy, prolonged, or arrives after a long gap and behaves strangely. In a condition defined by irregular bleeding this is easy to dismiss. It is the one symptom that most warrants a look.

What to do with the number

Count from the first day of your last bleed, not the last. If any single gap has passed 90 days, or you have had fewer than eight bleeds in the past year, that meets the definition and is worth booking on. If you are already under someone's care and the gaps are known about, this is a conversation rather than an urgent appointment.

Take the dates with you. Not an app export of everything — just the first day of your last three or four bleeds, and roughly what the pattern was before. It is the single most useful thing you can bring, and it changes the appointment more than any symptom description does.

Then ask the two questions that separate the branches above: what are we doing to protect the lining, and — if it applies — how will we know whether I'm ovulating. If bloods come back and you are left holding numbers nobody explained, we have written a plain-English guide to what the results actually mean.

And if what you really want to know is why your cycles behave this way in the first place, that depends on which driver is dominant — insulin, androgens, ovulation, SHBG, cortisol — and they are not managed the same way. Our free assessment takes a few minutes, needs no lab results, and gives you a read on which one looks likeliest for you. It is a starting point for the conversation, not a diagnosis.

Sources

• Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, et al. "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." The Journal of Clinical Endocrinology and Metabolism 2023 Sep 18;108(10):2447–2469. PMID 37580314. (Source of the cycle-irregularity definitions quoted above, including ">90 days for any 1 cycle" from one year post-menarche and "<8 cycles per year"; also the statements that the overall chance of endometrial cancer is low, that routine screening is not recommended, and that preventative strategies comprise weight management, cycle regulation and regular progestogen therapy. The guideline does not specify an interval between withdrawal bleeds.)
• Wang S, Wang YX, Sandoval-Insausti H, Farland LV, Shifren JL, Zhang D, Manson JE, Birmann BM, Willett WC, Giovannucci EL, Missmer SA, Chavarro JE. "Menstrual cycle characteristics and incident cancer: a prospective cohort study." Human Reproduction 2022 Jan 28;37(2):341–351. PMID 34893843. (Prospective cohort, 78,943 premenopausal women in the Nurses' Health Study II, 1989–2015, 5,794 incident cancers. Irregular cycles at ages 29–46 associated with endometrial cancer HR 1.39, 95% CI 1.09–1.77, adjusted for BMI. Not a PMOS-specific cohort.)
• Hosseinzadeh P, Barsky M, Gibbons WE, Blesson CS. "Polycystic Ovary Syndrome and the Forgotten Uterus." F&S Reviews 2021 Jan;2(1):11–20. PMID 34423324. (Systematic literature review of endometrial and uterine changes in PCOS, including progesterone resistance and endometrial hyperplasia; the authors' framing is that the uterine side of the condition is comparatively understudied.)
• The relationship between anovulation, unopposed oestrogen and endometrial proliferation is well-established general reproductive physiology and is not attributed to a single study here.